Diagnostic Products Corp.
Diagnostics company announces record sales and earnings
Published in Law and Health Weekly, August 28th, 2004
Earnings were $18.6 million, or $.62 per diluted share, an increase of 12% from $16.6 million or $.56 for the second quarter of 2003. The dollar weakened relative to the Euro, but strengthened relative to the Real in the second quarter of 2004. Overall changes in currencies had a 3% positive impact on sales. International sales were $78.4 million and domestic sales were $32.1 million.
Sales of IMMULITE products continued to be very strong, growing 18% over the second quarter of 2003. IMMULITE product line...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Aon Consulting
Firm offers advice on new CMS guidance on retiree drug coverage - Apria Healthcare Group, Inc.
Apria comments on proposed reimbursement for inhalation drugs - Association of Community Cancer Centers
Reductions in Medicare payment for drugs could impact continuum of cancer care - Children's Hospital Westmead
Routine childhood immunizations should not be compulsory - Chiron Corp.
Biotech names Ursula B. Bartels vice president and general counsel - Direction de Sante Publique de Montreal
Street youth more likely to die of suicide and drug overdose - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
